Skip to main content
. 2024 Nov 5;14:26793. doi: 10.1038/s41598-024-77331-8

Table 4.

The effect of age, COVID-19 history and underlying disease on specific antibodies.

Pasto Covac Plus vs. Soberana Plus
OR P value
Ig-S Seroconversion(Yes/No)
Crude 0.6 (0.2, 1.7) 0.355
Model 1
Seroconversion (Yes/No) 0.7 (0.3, 1.9) 0.480
    Age (Years) 1.0 (0.9, 1.0) 0.458
   Model 2:
    Seroconversion (Yes/No) 0.5 (0.2, 1.5) 0.246
COVID-19 (Yes/ No) 0.4 (0.1, 1.1) 0.062
    Model 3
     Seroconversion (Yes/No) 0.6 (0.2, 1.7) 0.337
     Comorbidity (Yes/ No) 0.8 (0.1, 4.2) 0.745
  Model 4
    Seroconversion (Yes/No) 0.6 (0.2, 1.7) 0.321
    Age (Years) 1.0 (0.9, 1.0) 0.632
    COVID-19 (Yes/ No) 0.4 (0.1, 1.1) 0.075
    Comorbidity (Yes/ No) 0.8 (0.1, 5.1) 0.858
Neutralizing Ab Seroconversion(Yes/No)
  Crude 0.8 (0.3, 2.2) 0.603
  Model 1
    Seroconversion (Yes/No) 0.7 (0.3, 1.9) 0.480
    Age (Years) 1.0 (0.9, 1.0) 0.458
   Model 2:
    Seroconversion (Yes/No) 0.5 (0.2, 1.5) 0.246
COVID-19 (Yes/ No) 0.4 (0.1, 1.1) 0.062
   Model 3
    Seroconversion (Yes/No) 0.8 (0.3, 2.3) 0.635
    Comorbidity (Yes/ No) 1.3 (0.2, 8.1) 0.763
   Model 4
    Seroconversion (Yes/No) 0.7 (0.2, 2.7) 0.585
    Age (Years) 1.0 (0.9, 1.1) 0.632
    COVID-19 (Yes/ No) 0.4 (0.1, 1.1) 0.075
    Comorbidity (Yes/ No) 2.2 (0.2, 28.0) 0.532